Utah Senator Orrin Hatch introduced a bill said to alleviate the underfunding problem of US pension funds.
Healthcare Health/Fitness
Actis to acquire 25% stake in Symbiotec Pharmalab
Actis planned to acquire 25% stake in Symbiotec Pharmalab. Actis, a private equity firm based in London, was looking to acquire a stake in Symbiotec Pharmalab.
Ipsen acquires Syntaxin
Ipsen announced the acquisition of UK-based private life sciences company, Syntaxin. Ipsen announced the acquisition of Syntaxin, a UK-based private life sciences company which specializes in botulinum toxin engineering.
Investors raise concern about Alexion valuation
Alexion Pharmaceuticals Inc sought potential buyers however investors raised concerns about the valuation of the company.
AG Barr in talks with Blackstone and Lion Capital
Sources revealed that AG Barr could be buying GlaxoSmithKline's Ribena and Lucozade brands. IRN-BRU producer AG Barr continued to be silent yesterday over reports AG Barr would team up with private equity organisations Blackstone Group and Lion Capital to purchase the Ribena and Lucozade brands from pharmaceutical giant GlaxoSmithKline.
Latest News
US hospitals shifted from the conventional paper record keeping to standardized electronic health records after receiving funds from the federal government.
The following bids, mergers, acquisitions and disposals were reported on Friday. The following bids, mergers, acquisitions and disposals were reported on Friday.
Roche Holding AG is currently seeking financing for a potential bid for Alexion Pharmaceuticals. Roche Holding AG announced that they are seeking financing for their potential bid for Alexion Pharmaceuticals Inc.
Global equity firm Riverside company purchased a share in a New Zealand firm that caters to pharma companies.
Integrated Solutions Group acquired Data Stratedies, Inc to strengthen its position in the medical community.
Conatus Pharmaceuticals offered 5 million shares for another IPO. Conatus Pharmaceuticals Inc. announced that it will be offering 5 million shares for another initial public offering.
Simcro sells Riverside Co enough shares for the American company to control it. The Riverside Co. , a U. S. private equity firm, has made its primary entry into New Zealand, taking up a large percentage of the stake in Simcro Ltd.
BMG Pharma enters into a long-term partnership Luqa Pharmaceuticals to distribute medical products in Hong Kong and China.
MPTC to acquire 60% stake claim for Medicago for US$357 million Medicago Inc announced that it has entered into a definitive agreement with Mitsubishi Tanabe Pharma Corporation (MPTC).
